Precigen Company Leadership
| PGEN Stock | USD 0.93 0.02 2.20% |
Precigen's insiders are aggressively buying. The analysis of the overall insider sentiment regarding Precigen suggests that virtually all insiders are extremely bullish. Precigen employs about 202 people. The company is managed by 15 executives with a total tenure of roughly 472 years, averaging almost 31.0 years of service per executive, having 13.47 employees per reported executive.
Precigen's Insider Buying Vs Selling
100
Selling | Buying |
Latest Trades
| 2024-08-09 | Jeffrey Thomas Perez | Acquired 58823 @ 0.85 | View | ||
| 2023-12-28 | Randal J Kirk | Acquired 96686 @ 1.41 | View |
Monitoring Precigen's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Precigen |
Precigen Management Team Effectiveness
The company has return on total asset (ROA) of (0.4232) % which means that it has lost $0.4232 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.2932) %, meaning that it created substantial loss on money invested by shareholders. Precigen's management efficiency ratios could be used to measure how well Precigen manages its routine affairs as well as how well it operates its assets and liabilities. As of the 30th of November 2024, Return On Tangible Assets is likely to drop to -1.2. In addition to that, Return On Capital Employed is likely to drop to -0.73. At this time, Precigen's Non Currrent Assets Other are very stable compared to the past year. As of the 30th of November 2024, Intangible Assets is likely to grow to about 78.7 M, while Total Assets are likely to drop about 143.5 M.As of the 30th of November 2024, Net Income Applicable To Common Shares is likely to grow to about 34.2 M, while Common Stock Shares Outstanding is likely to drop about 134.9 M.
Precigen Workforce Comparison
Precigen is regarded fifth in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 2,896. Precigen holds roughly 202 in number of employees claiming about 7% of equities under Health Care industry.
Precigen Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Precigen insiders, such as employees or executives, is commonly permitted as long as it does not rely on Precigen's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Precigen insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Tennant Phil over three months ago Insider Trading | ||
Donald Lehr over six months ago Acquisition by Donald Lehr of 400000 shares of Precigen at 1.4 subject to Rule 16b-3 | ||
Gupta Vinita D over six months ago Acquisition by Gupta Vinita D of 87412 shares of Precigen subject to Rule 16b-3 | ||
Donald Lehr over six months ago Acquisition by Donald Lehr of 164285 shares of Precigen subject to Rule 16b-3 | ||
Kirk Randal J over six months ago Disposition of 691929 shares by Kirk Randal J of Precigen subject to Rule 16b-3 | ||
Harry Thomasian over six months ago Acquisition by Harry Thomasian of 135714 shares of Precigen subject to Rule 16b-3 | ||
Donald Lehr over six months ago Disposition of 164285 shares by Donald Lehr of Precigen subject to Rule 16b-3 | ||
Frank Steven over six months ago Acquisition by Frank Steven of 87412 shares of Precigen subject to Rule 16b-3 |
Precigen Notable Stakeholders
A Precigen stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Precigen often face trade-offs trying to please all of them. Precigen's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Precigen's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Helen MPH | CEO President | Profile | |
| Helen Sabzevari | CEO President | Profile | |
| Randal JD | Executive Chairman | Profile | |
| Rob Russell | VP Resources | Profile | |
| Mr JD | Chief Secretary | Profile | |
| Donald Lehr | Chief Secretary | Profile | |
| Rutul Shah | Chief Officer | Profile | |
| Jeffrey Perez | Senior Affairs | Profile | |
| Jeffrey JD | Senior Affairs | Profile | |
| Steven Harasym | VP Relations | Profile | |
| Douglas Brough | Senior Research | Profile | |
| Harry Thomasian | Chief Officer | Profile | |
| Bryan Butman | Senior CMC | Profile | |
| Marie Rossi | Vice Communications | Profile | |
| Thomas Reed | Founder Officer | Profile |
About Precigen Management Performance
The success or failure of an entity such as Precigen often depends on how effective the management is. Precigen management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Precigen management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Precigen management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.15) | (1.20) | |
| Return On Capital Employed | (0.69) | (0.73) | |
| Return On Assets | (0.63) | (0.67) | |
| Return On Equity | (0.81) | (0.85) |
Precigen Workforce Analysis
Traditionally, organizations such as Precigen use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Precigen within its industry.Precigen Manpower Efficiency
Return on Precigen Manpower
| Revenue Per Employee | 30.8K | |
| Revenue Per Executive | 415K | |
| Net Loss Per Employee | 474.8K | |
| Net Loss Per Executive | 6.4M | |
| Working Capital Per Employee | 226.6K | |
| Working Capital Per Executive | 3.1M |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Precigen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Precigen Stock, please use our How to Invest in Precigen guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precigen. If investors know Precigen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Precigen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.54) | Revenue Per Share 0.018 | Quarterly Revenue Growth (0.59) | Return On Assets (0.42) | Return On Equity (1.29) |
The market value of Precigen is measured differently than its book value, which is the value of Precigen that is recorded on the company's balance sheet. Investors also form their own opinion of Precigen's value that differs from its market value or its book value, called intrinsic value, which is Precigen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Precigen's market value can be influenced by many factors that don't directly affect Precigen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Precigen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Precigen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Precigen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.